Article

Artificial tear protects and lasts to improve dry eye signs

Author(s):

Clinical practice experience is confirming the results from premarketing clinical trials that showed a new over-the-counter artificial tear product (Systane, Alcon) is a novel approach for modulating the signs and symptoms of dry eye.

Related Videos
John Saharek, president of ImprimisRX, speaks with Ophthalmology Times' David Hutton on three new products the company will be featuring during the American Academy of Ophthalmology's 2021 annual meeting
What keeps you up at night in ophthalmology: Part II
Chris Adams, Diopter Corp CEO
Ramin Valian, of Allergan, discusses pharmaceuticals in the glaucoma industry at Glaucoma 360
© 2024 MJH Life Sciences

All rights reserved.